NTRA Q4 2024 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

Q4 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$476M+53.0% YoY

Gross Profit

$300M62.9% margin

Operating Income

-$65M-13.6% margin

Net Income

-$54M-11.3% margin

EPS (Diluted)

$-0.41

QoQ Revenue Growth

+8.3%

Cash Flow

Operating Cash Flow

$53M

Free Cash Flow

$35M

Stock-Based Comp.

$72M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$465M

Stockholders' Equity

$1.2B

Cash & Equivalents

$946M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$476M	$311M	+53.0%
Gross Profit	$300M	$160M	+87.4%
Operating Income	-$65M	-$85M	+23.4%
Net Income	-$54M	-$78M	+31.1%

Revenue Segments

Product

$884M99%

Licensing and other

$5M1%

Geographic Segments

United States

$467M98%

Europe, Middle East, India, Africa

$6M1%

Asia Pacific and Other

$2M0%

Americas, excluding U.S.

$2M0%